临床心理学
苦恼
医学
基因检测
考试(生物学)
癌症
风险评估
内科学
古生物学
计算机安全
计算机科学
生物
作者
David Cella,Chanita Hughes,Amy H. Peterman,Chih‐Hung Chang,Beth N. Peshkin,Marc D. Schwartz,Lari Wenzel,Amy A. Lemke,Alfred C. Marcus,Caryn Lerman
出处
期刊:Health Psychology
[American Psychological Association]
日期:2002-01-01
卷期号:21 (6): 564-572
被引量:265
标识
DOI:10.1037/0278-6133.21.6.564
摘要
The Multidimensional Impact of Cancer Risk Assessment (MICRA) is a new tool to measure the specific impact of result disclosure after genetic testing. The authors compared its performance with that of questionnaires measuring general and cancer-specific distress. Participants (158 women) responded 1 month after they received genetic test results. The women were divided into 4 standard clinical test result groups: BRCA1/2 positive, BRCA1/2 negative, panel negative, and true negative. Factor analysis supported the formation of 3 subscales: Distress (6 items, alpha = .86), Uncertainty (9 items, alpha = .77), and Positive Experiences (4 items, alpha = .75). All 3 MICRA subscales differentiated participants who were BRCA1/2 positive from the other 3 groups. MICRA thus helps identify subgroups of vulnerable genetic testing participants.
科研通智能强力驱动
Strongly Powered by AbleSci AI